ECSP003448A - Azoles sustituidos - Google Patents

Azoles sustituidos

Info

Publication number
ECSP003448A
ECSP003448A ECSP003448A ECSP003448A EC SP003448 A ECSP003448 A EC SP003448A EC SP003448 A ECSP003448 A EC SP003448A EC SP003448 A ECSP003448 A EC SP003448A
Authority
EC
Ecuador
Prior art keywords
azols
substituted
diseases
tnf
graph
Prior art date
Application number
Other languages
English (en)
Inventor
Achim Schlapbach
Laszlo Revesz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003448 priority Critical patent/ECSP003448A/es
Publication of ECSP003448A publication Critical patent/ECSP003448A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Los compuestos de la fórmula I (gráfico), en donde los simbolos tienen los significados definidos en la presente, son inhibidores de cinasa MAP p38, y son útiles farmacéuticamente para el tratamiento de enfermedades mediadas por TNF e IL-1, tales como artritis reumatoide, y enfermedades del metabolismo óseo, por ejemplo osteoporosis.
ECSP003448 2000-04-27 2000-04-27 Azoles sustituidos ECSP003448A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003448 ECSP003448A (es) 2000-04-27 2000-04-27 Azoles sustituidos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003448 ECSP003448A (es) 2000-04-27 2000-04-27 Azoles sustituidos

Publications (1)

Publication Number Publication Date
ECSP003448A true ECSP003448A (es) 2000-05-25

Family

ID=42041076

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003448 ECSP003448A (es) 2000-04-27 2000-04-27 Azoles sustituidos

Country Status (1)

Country Link
EC (1) ECSP003448A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9029409B2 (en) 2011-04-30 2015-05-12 Abbvie Inc. Isoxazolines as therapeutic agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9029409B2 (en) 2011-04-30 2015-05-12 Abbvie Inc. Isoxazolines as therapeutic agents

Similar Documents

Publication Publication Date Title
AR023465A1 (es) Azoles sustituidos
CY1107094T1 (el) Φθοροϋποκατεστημενη ωμεγα-καρβοξυαρυλ διφαινυλ ουρια για τη θεραπεια και προληψη ασθενειων και καταστασεων
ECSP055640A (es) Composiciones de pirazol útiles como inhibidores de gsk-3
SI1580188T1 (sl) Aril sečnine kot kinazni inhibitorji
UY27234A1 (es) Inhibidores novedosos de tirosina cinasa
PE20050523A1 (es) Pirazoles como inhidores de factor de necrosis tumoral
GB0121033D0 (en) Organic compounds
UY27729A1 (es) Inhibidores de quinasas.
CY1109519T1 (el) Κεκορεσμενες και ακορεστες 3-πυριδυλο-βενζοκυκλοαλκυλομεθυλαμινες για τη θεραπεια πονων, καταθλιψεων και καταστασεων φοβου
GB0220187D0 (en) Organic compounds
ATE331718T1 (de) Spirosubstituierte pyrrolopyrimidine
ECSP088906A (es) PIRAZOLO 1,5-a PIRIMIDINAS
ECSP034809A (es) Ciclobuteno-1,2-dionas 3,4-disustituidas como ligandos del receptor de quimocina cxc
PA8493701A1 (es) Compuestos para tratar la obesidad
CO5271715A1 (es) 7-aza-indolin-2-onas sustituidas en 4 y su uso como inhibidores de proteiuna quinasa
EA200870415A1 (ru) Хиназолины для ингибирования pdk 1
PA8596901A1 (es) Inhibidores de p38 y metodos de uso de ellos
GB0112348D0 (en) Compounds
CR6706A (es) Pirido (2,3-d) pirimidin-2-7-diaminas inhibidores de cinasas
SE0302139D0 (sv) Novel compounds
NO20054361D0 (no) Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte
ECSP066986A (es) Beta-carbolinas utiles para tratar enfermedades inflamatorias
PA8633201A1 (es) Tieno [3,2-b]piridin-6-carbonitrilos como inhibidores de la quinasa proteica
ECSP003448A (es) Azoles sustituidos
MY128242A (en) Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf